Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
37019628	f-baktnho	— (—)	13412	17403	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications: azathioprine

693

1414

5.31

323.01

1.5

1.2

—

Implicit Sepsis, including avohilmo

2567

7925

2.38

323.01

1.4

1.2

—

Viral and other specified intestinal infections, including avohilmo

1051

2812

3.77

319.46

1.4

1.2

—

Malaise and fatigue

1695

4791

2.88

319.24

1.4

1.2

—

Azathioprine

693

1441

5.21

316.02

1.5

1.2

—

Headache

2035

6247

2.59

312.52

1.3

1.2

—

Renal failure

1683

5278

2.83

310.19

1.5

1.3

—

Symptoms and signs involving the digestive system and abdomen

2854

5923

2.48

307.65

1.4

1.3

—

Ulcerative colitis, NAS

848

1345

7.08

307.65

1.5

1.3

—

Autoimmune diseases related-to ILD

3103

9842

2.73

307.65

1.4

1.3

—

Mucosal proctocolitis

759

1186

7.17

307.65

1.5

1.3

—

General symptoms and signs

3125

6695

2.40

307.65

1.4

1.2

—

Bacterial intestinal infections, IBD co-morbidities

1171

2196

5.98

307.65

1.8

1.3

—

Nausea and vomiting

1075

2773

3.99

307.65

1.4

1.2

—

Implicit bacterial Sepsis, including avohilmo

1799

4735

3.32

307.65

1.5

1.2

—

Other noninfective gastroenteritis and colitis

1480

2849

5.74

307.65

1.5

1.3

—

Constipation

2823

8486

2.32

307.65

1.3

—

Abdominal and pelvic pain

2782

5923

2.42

307.65

1.3

—

Inflammatory bowel disease treatment related agents

4062

8262

2.82

307.65

1.4

1.2

—

Other bacterial diseases, including avohilmo

3360

8490

2.55

307.65

1.5

1.2

—

Collagenous colitis

655

997

7.64

307.65

1.5

1.3

—

Renal tubulo-interstitial diseases

2850

8956

2.40

307.65

1.5

1.3

—

Infections, IBD-co-morbidities

1047

712

11.53

307.65

1.8

1.3

—

Fever of other and unknown origin

2236

5739

3.53

307.65

1.6

1.2

—

Inflammatory bowel disease, strict (require KELA)

1381

2646

5.78

307.65

1.5

1.3

—

ILD medications: immunosuppressive drugs

2475

7044

3.33

307.65

1.6

1.2

—

Intestinal infectious diseases, including avohilmo, including avohilmo

5514

6837

4.76

307.65

1.4

1.2

—

Bacterial Sepsis

1839

4872

3.27

307.65

1.5

1.2

—

Other bacterial diseases

3327

8265

2.76

307.65

1.5

1.2

—

Budesonide

1078

1452

8.58

307.65

1.5

1.3

—

Other diseases of intestines

3690

7137

2.98

307.65

1.4

1.3

—

Noninfectious colitis NAS

846

1442

6.58

307.65

1.6

1.3

—

Certain infectious and parasitic diseases

2953

5097

2.99

307.65

1.4

1.2

—

Other septicaemia

1394

4249

3.24

307.65

1.6

1.2

—

IBD patients in KELA-register

1381

2392

6.40

307.65

1.5

1.3

—

Certain infectious and parasitic diseases, including avohilmo

1915

2859

3.45

307.65

1.4

1.1

—

Autoimmune diseases excluding thyroid diseases

3305

7612

2.42

307.65

1.4

1.3

—

Inflammatory bowel disease

1746

3831

4.97

307.65

1.4

1.3

—

Crohn disease

730

1242

6.53

307.65

1.5

1.3

—

Bacterial infection, other or unspecified

2312

5666

3.64

307.65

1.6

1.2

—

Diseases of oesophagus, stomach and duodenum

3274

8693

2.28

307.65

1.4

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

4869

7168

4.62

307.65

1.4

1.2

—

GASTRO-related operations

2192

3797

2.97

307.65

1.4

1.1

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

763

1509

5.56

307.65

1.4

1.3

—

All kidney diseases

3071

9272

2.28

307.65

1.4

1.3

—

Ulcerative colitis

1339

2661

5.51

307.65

1.5

1.3

—

First line medication for Crohn's disease

3811

7431

2.85

307.65

1.4

1.2

—

Enterocolitis due to Clostridium difficile

779

1179

7.64

307.65

1.9

1.2

—

Intestinal infectious diseases

4428

8819

3.94

307.65

1.4

1.2

—

Explicit Sepsis, including avohilmo

1623

5100

3.01

307.65

1.6

1.2

—

Other septicaemia, including avohilmo

1416

4325

3.22

307.65

1.6

1.2

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1001

2022

5.46

307.65

1.5

1.3

—

Septicaemia

1534

4647

3.15

307.65

1.6

1.2

—

5-aminosalicylic acid

1231

2139

6.34

307.65

1.5

1.3

—

Oral corticosteroids

3612

8030

2.73

307.65

1.4

1.2

—

Implicit bacterial Sepsis

1654

4349

3.43

307.65

1.5

1.2

—

Explicit Sepsis

1592

5007

3.02

307.65

1.6

1.2

—

Transplanted organ and tissue status

563

932

6.80

307.65

2.6

1.2

—

Ulcerative colitis (strict definition, require KELA)

953

1865

5.65

307.65

1.5

1.3

—

Other bacterial intestinal infections

1179

1782

7.45

307.65

1.8

1.2

—

Other functional intestinal disorders

1879

4604

3.90

307.65

1.4

1.3

—

Implicit Sepsis

2517

7369

2.60

307.65

1.4

1.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3065

9331

2.28

307.65

1.5

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

3192

7403

2.41

307.65

1.4

1.3

—

ILD medications

3841

7874

2.71

307.65

1.5

1.2

—

Any gastric operation

2192

3797

2.97

307.65

1.4

1.1

—

Noninfective enteritis and colitis

2759

5707

5.27

307.65

1.5

1.3

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

939

1789

5.82

307.65

1.5

1.3

—

Other bacterial intestinal infections, including avohilmo

1546

2416

7.18

307.65

1.7

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

3388

7590

4.23

307.65

1.4

1.2

—

Bacterial infection, other or unspecified, including avohilmo

2462

6033

3.52

307.65

1.6

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

3707

7753

2.75

307.65

1.4

1.2

—

Irritable bowel syndrome

1279

2913

4.70

307.65

1.4

1.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2664

6831

2.34

307.18

1.5

1.2

—

2664

6831

2.34

307.18

1.5

1.2

—

Diverticular disease of intestine

2046

4982

2.63

306.39

1.3

—

Non-invasive ventilation

936

2088

4.07

306.20

1.4

1.3

—

Second line medication for Crohn's disease

1982

8111

2.53

303.94

1.4

1.3

—

Implicit viral Sepsis, including avohilmo

1174

3676

3.36

299.16

1.5

1.2

—

Tramadol

2280

5692

2.47

298.77

1.4

1.2

—

Gastrointestinal diseases

1468

2322

3.25

295.46

1.3

1.2

—

Gastro-oesophageal reflux disease

2153

7696

2.43

294.64

1.4

1.3

—

Medical observation and evaluation for suspected diseases and conditions

1839

3432

2.81

293.83

1.4

1.2

—

Oxycodone

1346

3871

3.10

292.06

1.6

1.2

—

Autoimmune diseases

3170

7649

2.15

289.59

1.4

1.3

—

Anaemias

780

1074

4.87

287.57

1.6

1.2

—

Pain in joint

1693

3810

2.81

285.77

1.3

—

Codeine

2613

6314

2.29

281.72

1.3

1.2

—

Other symptoms and signs involving the digestive system and abdomen

713

1664

4.58

280.92

1.5

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2535

8043

2.24

276.22

1.4

1.2

—

Influenza and pneumonia

3105

9414

2.08

274.72

1.5

1.2

—

Pneumonia, organism unspecified

2719

8850

2.16

270.29

1.5

1.2

—

Other soft tissue disorders, not elsewhere classified

2712

7195

2.20

268.48

1.3

—

Opioids

2695

6408

2.22

267.46

1.4

1.2

—

Other Crohn's disease

400

583

7.73

266.37

1.5

1.3

—

Acute renal failure

914

2654

3.67

265.03

1.6

1.3

—

Viral Sepsis

868

2437

3.79

264.58

1.6

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

2963

9528

2.08

264.40

1.5

1.2

—

Implicit viral Sepsis

866

2434

3.78

263.54

1.6

1.2

—

6-mercaptopurine

280

271

12.34

260.75

1.5

1.2

—

All pneumoniae

2973

9573

2.06

260.29

1.5

1.2

—

Used for control exclusion in common control thyroid runs

2925

7089

2.13

259.37

1.4

1.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2894

9563

2.06

254.02

1.5

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2586

8317

2.15

253.45

1.4

1.2

—

Persons encountering health services for specific procedures and health care

3071

9116

2.03

252.18

1.4

1.3

—

Complications of surgical and medical care, not elsewhere classified

2918

9730

2.05

251.43

1.5

1.2

—

Abnormalities of breathing

2497

6626

2.20

250.64

1.4

1.3

—

General examination and investigation of persons without complaint and reported diagnosis

1714

3429

2.66

249.28

1.4

1.2

—

All chronic kidney diseases

1718

5630

2.51

248.62

1.5

1.3

—

Pain in throat and chest

2377

6479

2.22

245.29

1.3

—

Examination and observation for other reasons

1593

3413

2.70

244.77

1.3

1.2

—

Ulcerative rectosigmoiditis

424

722

6.51

242.20

1.4

1.3

—

Pain in limb

2373

7049

2.19

240.58

1.3

—

Hernia of abdominal wall, postoperative

605

1408

4.48

235.09

1.5

1.1

—

Complications of medical and surgical care

2234

9564

2.16

233.54

1.5

1.3

—

Care involving dialysis

421

741

6.34

232.96

1.6

1.3

—

Crohn's disease of small intestine

375

600

6.98

228.35

1.5

1.3

—

Paralytic ileus and intestinal obstruction

854

2598

3.43

228.05

1.5

1.3

—

Low back pain

2242

7134

2.17

226.01

1.3

—

L04AX Other immunosuppressants

1774

7956

2.30

220.69

1.4

1.3

—

Codeine or tramadol medication

3125

8954

1.93

219.43

1.3

—

Dental caries

835

2404

3.42

218.82

1.6

1.3

—

Acute tubulo-interstitial nephritis

1901

7370

2.24

215.47

1.4

1.2

—

Asthma, unspecified (mode), excluding more controls

1442

4126

2.57

214.41

1.3

1.2

—

Chronic kidney disease

1088

3787

2.89

213.60

1.6

1.2

—

Other diseases of anus and rectum

940

3183

3.06

207.83

1.4

1.3

—

Other ulcerative colitis

321

484

7.46

207.24

1.6

1.3

—

Heart failure, not strict

2091

6678

2.16

207.05

1.4

1.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1640

3433

2.47

205.76

1.4

1.2

—

Caries of dentine

752

2162

3.51

205.76

1.6

1.3

—

Asthma, unspecified (mode)

1483

4428

2.48

205.74

1.3

1.2

—

COPD/asthma related infections

2684

6831

2.01

205.17

1.4

1.2

—

COPD/asthma/ILD related infections

2684

6831

2.01

205.17

1.4

1.2

—

Dialysis, with operation codes

537

1300

4.47

202.91

1.6

1.3

—

Diseases of the digestive system

1450

6157

2.42

201.63

1.4

1.3

—

Covid-19 confirmed case

1258

5055

2.59

201.16

1.4

1.3

—

Polyarthropathies

1861

5468

2.24

199.65

1.4

1.3

—

Dyspnoea

2533

9502

1.97

198.80

1.4

1.3

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

375

708

5.90

192.66

1.5

1.3

—

Crohn disease (strict definition, require KELA)

360

656

6.14

192.35

1.5

1.4

—

Crohn disease (strict definition, require KELA, min 2 HDR)

357

647

6.18

191.90

1.5

1.4

—

Parasetamol

1776

3977

2.30

191.39

1.3

—

Viral and other specified intestinal infections

698

2033

3.49

191.11

1.4

1.2

—

Other disorders of fluid, electrolyte and acid-base balance

1053

3740

2.76

189.80

1.5

1.3

—

Biological medication for rheuma

699

2128

3.48

188.19

1.5

1.3

—

Other specific joint derangements/joint disorders

2033

6132

2.11

187.84

1.3

—

Symptoms and signs involving the circulatory and respiratory systems

2566

6644

1.97

186.99

1.4

1.3

—

Codes for special purposes

1637

7546

2.21

186.06

1.4

1.3

—

Complications of procedures, not elsewhere classified

2267

9426

1.98

185.75

1.4

1.2

—

Nephropathy related operations

512

1280

4.32

185.44

1.6

1.3

—

Provisional assignment of new diseases of uncertain etiology

1634

7541

2.21

185.22

1.4

1.3

—

3032

8437

1.85

185.13

1.4

1.2

—

L04AD Calcineurin inhibitors

475

1142

4.51

181.42

1.9

1.3

—

Metabolic disorders

2507

7937

1.93

180.27

1.4

1.3

—

Crohn's disease NAS

318

555

6.33

177.15

1.7

1.3

—

Lower back pain or/and sciatica

2933

10225

1.82

175.65

1.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2909

8558

1.84

174.95

1.3

—

Asthma, excluding more controls

1814

4339

2.19

174.70

1.3

1.2

—

Dorsalgia

2579

7285

1.91

174.27

1.3

—

Other pulmonary diagnosis

1955

4699

2.13

173.92

1.4

1.2

—

Persons encountering health services in other circumstances, wide

2989

8582

1.82

173.23

1.3

—

Oedema, not elsewhere classified

963

3566

2.73

172.46

1.4

1.2

—

Asthma

1888

4654

2.13

170.94

1.3

1.2

—

Other or unspecified ileus, impaction or obstruction

606

1786

3.55

170.68

1.5

1.3

—

Pain (limb, back, neck, head abdominally)

1713

3934

2.22

170.25

1.3

—

Excluding asthma or asthma-COPD overlap

1942

4699

2.11

169.86

1.4

1.2

—

Other disorders of urethra and urinary system

1943

6748

2.05

169.83

1.4

1.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1758

8535

2.07

168.59

1.6

1.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2599

9023

1.85

167.00

1.5

1.2

—

ILD differential diagnosis

1929

4694

2.10

166.30

1.4

1.2

—

COPD differential diagnosis

1929

4695

2.10

166.24

1.4

1.2

—

Mood disorders, excluding more controls

2483

7893

1.88

164.94

1.3

—

Persons encountering health services in other circumstances

1239

5363

2.35

163.33

1.4

1.3

—

Crohn's disease of large intestine

266

424

7.00

162.72

1.5

1.3

—

Crohn disease (strict definition, all UC cases excluded)

284

494

6.45

159.50

1.4

1.3

—

Intestinal stricture

1005

4073

2.57

158.60

1.5

1.3

—

Asthma (mode)

1832

4694

2.09

158.27

1.3

1.2

—

Other dorsopathies, not elsewhere classified

2557

7295

1.85

156.80

1.3

—

Dysphagia

746

2619

2.96

155.95

1.3

—

Aplastic and other anaemias

1375

5830

2.22

155.54

1.6

1.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2562

9628

1.81

154.50

1.3

—

Soft tissue disorders

2565

7248

1.84

154.46

1.3

—

L04AA Selective immunosuppressants

784

2857

2.88

153.97

1.6

1.3

—

Tumor necrosis factor alpha inhibitors

598

1876

3.37

153.31

1.5

1.3

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1093

2970

2.51

152.98

1.3

1.2

—

Benzodiazepine use

2681

10365

1.78

152.23

1.3

—

Other diseases of urinary system

2508

7819

1.83

151.48

1.4

1.3

—

Anxiety disorders, excluding more controls

2179

7469

1.90

151.45

1.3

—

Extracorporeal dialysis

305

597

5.70

150.76

1.7

1.3

—

Benign neoplasm of colon, rectum, anus and anal canal

1774

7682

2.00

150.66

1.3

—

Pain, not elsewhere classified

826

3116

2.74

150.28

1.4

1.2

—

Haemorrhoids and perianal venous thrombosis

918

3620

2.59

149.88

1.3

—

Ulcerative proctitis

282

521

5.92

147.67

1.4

1.3

—

Erysipelas, including avohilmo

1823

6984

1.97

146.02

1.4

1.2

—

Bronchitis

2868

10094

1.73

145.83

1.4

1.3

—

Asthma (only as main-diagnosis), excluding more controls

1624

4339

2.11

145.78

1.3

1.2

—

Any reimbursement code in KELA

1341

2983

2.30

143.74

1.4

1.1

—

Abnormalities of heart beat

1014

4167

2.43

143.14

1.3

—

Other antidepressants

2552

7349

1.80

143.00

1.3

—

Diseases of the skin and subcutaneous tissue

2445

6832

1.82

142.20

1.4

1.3

—

Symptoms and signs involving the urinary system

2046

8383

1.88

141.92

1.4

1.3

—

Disorders of gallbladder, biliary tract and pancreas

2547

9091

1.77

141.63

1.4

1.3

—

Other intervertebral disc disorders

2074

6642

1.90

141.27

1.3

—

Nutritional anaemias

1442

6760

2.09

140.53

1.5

1.3

—

Acute upper respiratory infections

2712

9487

1.74

140.53

1.4

1.3

—

Asthma (only as main-diagnosis)

1674

4654

2.05

139.74

1.3

1.2

—

Other and unspecified anaemias

1251

5493

2.20

138.92

1.6

1.3

—

Other anaemias

1258

5523

2.19

138.61

1.6

1.3

—

Spondylopathies

1951

6111

1.92

138.40

1.3

—

Mood disorders

2660

9971

1.73

137.67

1.3

—

Erysipelas

1421

5993

2.09

137.29

1.3

1.2

—

Mood [affective] disorders

2654

9971

1.73

137.16

1.3

—

Depression

2496

9650

1.76

136.97

1.3

—

Kidney transplant status

264

499

5.90

135.69

1.5

1.3

—

Liquid cancers, including Hilmo

1046

4036

2.36

135.07

2.0

1.2

—

Cough

1110

4677

2.27

133.98

1.4

1.3

—

Syncope and collapse

1147

4346

2.25

133.42

1.4

1.2

—

Cystitis

2147

7063

1.84

133.41

1.4

1.3

—

Dizziness and giddiness

1990

8537

1.85

132.17

1.3

—

Dorsopathies

2512

7320

1.76

131.34

1.3

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

757

1327

2.92

129.57

1.4

1.1

—

Persons encountering health services for examination and investigation

1435

3433

2.13

129.49

1.4

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

2021

8190

1.83

129.39

1.4

1.3

—

Osteopathies and chondropathies

1582

7556

1.96

128.55

1.4

1.3

—

Infliximab

166

207

9.60

128.22

1.4

1.2

—

All influenza

785

3126

2.60

128.22

1.5

1.2

—

Implicit fungal Sepsis, including avohilmo

326

770

4.61

127.77

1.7

1.2

—

Neurotic, stress-related and somatoform disorders

2318

9257

1.75

126.93

1.3

—

Iron deficiency anaemia

1246

5933

2.12

126.60

1.4

1.3

—

Depression or dysthymia

1634

4558

1.99

126.31

1.3

—

Other disorders of skin and subcutaneous tissue

1937

9130

1.83

125.57

1.4

1.3

—

Other diseases of the digestive system

942

4116

2.36

125.32

1.4

1.3

—

Anxiety disorders

2332

9331

1.74

124.87

1.3

—

Episodal and paroxysmal disorders

2686

8113

1.70

124.48

1.3

—

Benign neoplasm: Colon

1490

7259

1.98

124.24

1.4

1.3

—

Other diseases of intestine

479

1492

3.36

123.79

1.4

1.3

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1578

8365

1.93

123.72

1.4

1.3

—

Liquid cancers

866

3459

2.45

123.45

2.1

1.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1770

8429

1.87

123.35

1.5

1.3

—

Continuous positive airway pressure

532

1430

3.22

123.31

1.4

1.3

—

Asthma, hospital admission 2, infections

1627

8538

1.90

121.81

1.4

1.3

—

Asthma-related infections

1627

8538

1.90

121.81

1.4

1.3

—

Use of hypnotics and sedatives

2611

8987

1.69

119.45

1.4

1.3

—

Finngen Rheumatological endpoints

2337

7756

1.74

118.88

1.4

1.3

—

Total colectomy

228

427

6.02

118.75

1.7

1.3

—

Total colectomy operation

228

427

6.02

118.75

1.7

1.3

—

Nerve, nerve root and plexus disorders

2665

9747

1.67

118.13

1.3

—

Shoulder lesions

1824

5986

1.86

117.25

1.3

—

Dermatitis and eczema

2820

10325

1.64

117.24

1.4

1.3

—

Other joint disorders

2119

6270

1.79

117.15

1.3

—

Myalgia

714

2856

2.59

115.64

1.3

—

GI-bleeding

918

4104

2.31

115.60

1.4

1.3

—

Functional dyspepsia

790

3340

2.45

113.48

1.4

1.3

—

Symptoms and signs involving the skin and subcutaneous tissue

1891

10261

1.77

113.23

1.4

1.3

—

Acute sinusitis

1381

6570

1.95

111.39

1.5

1.3

—

Disorders of eyelid, lacrimal system and orbit

2215

9670

1.71

111.23

1.3

—

Sleep disorders (combined)

2723

8776

1.64

111.15

1.3

—

Preparatory care for dialysis

229

459

5.62

110.69

1.7

1.3

—

Other headache syndromes

1130

5548

2.08

110.43

1.3

—

Infections of the skin and subcutaneous tissue

1543

8299

1.87

110.18

1.4

1.3

—

Primary_lymphoid and hematopoietic malignant neoplasms

735

3085

2.48

107.79

2.1

1.3

—

Volume depletion

349

977

3.78

107.13

1.7

1.3

—

Migraine

1343

5440

1.96

106.97

1.3

—

Other and unspecified iron deficiency

989

4697

2.16

106.56

1.4

1.3

—

Recurrent or chronic depression

1009

3267

2.19

105.36

1.3

—

Bleeding

2053

8510

1.72

105.32

1.4

1.3

—

Diseases of the respiratory system

1465

3827

1.95

104.41

1.4

1.2

—

Dialysis

197

364

6.04

103.89

1.5

1.2

—

Other anxiety disorders

1241

5449

1.98

103.22

1.3

—

Other heart diseases

1110

3506

2.10

102.80

1.4

1.3

—

Anxiety (asthma-related co-morbidities)

1543

6463

1.85

102.49

1.3

—

Special screening examination for infectious and parasitic diseases

596

1624

2.74

102.17

1.3

1.2

—

Sciatica+with lumbago

1289

6003

1.94

101.93

1.3

—

Genitourinary diseases

1204

2963

2.07

101.22

1.4

1.2

—

Other heart diseases, wide

2183

7974

1.68

100.33

1.3

—

Candidiasis, including avohilmo

908

4285

2.19

100.25

1.5

1.3

—

Diaphragmatic hernia

1003

4918

2.10

99.94

1.3

—

Other medical care

1249

5484

1.95

99.61

1.5

1.3

—

Secondary hypertension

269

652

4.30

98.56

1.5

1.3

—

All anxiety disorders

1583

6920

1.81

98.18

1.3

—

Heart failure,strict

1288

4724

1.95

97.78

1.4

1.3

—

Fall on same level

2742

9335

1.59

97.56

1.3

—

Gout

718

2636

2.41

97.14

1.5

1.3

—

Intracranial trauma

1369

4951

1.90

96.99

1.3

—

Neurological diseases

1958

5746

1.73

96.94

1.3

—

Concussion

1211

4885

1.96

96.28

1.3

—

Glomerular diseases

554

2155

2.68

95.75

1.4

1.3

—

Pure hypercholesterolaemia

1774

6538

1.75

95.29

1.3

—

Glomerular disorders in diseases classified elsewhere

386

1249

3.26

94.27

1.5

1.3

—

Disorders of lipoprotein metabolism and other lipidaemias

1918

6923

1.71

94.02

1.3

—

Mycoses, including avohilmo

2289

10945

1.62

93.97

1.4

1.3

—

Other reaction to severe stress, and adjustment disorders

962

4743

2.08

93.77

1.4

1.3

—

1204

6368

1.92

93.49

1.4

1.3

—

Care involving use of rehabilitation procedures

1519

7774

1.79

93.29

1.3

—

Hypothyroidism (congenital or acquired)

558

1134

2.81

93.22

1.3

1.2

—

Adalimumab

347

1069

3.43

91.94

1.5

1.3

—

Selective serotonin reuptake inhibitors

2287

7367

1.63

91.70

1.3

—

Cardiac arrhythmias

1403

4929

1.86

91.49

1.3

—

Dermatitis

1583

9012

1.75

91.20

1.4

1.3

—

Other disorders of lacrimal gland

1031

5283

2.00

90.76

1.4

1.3

—

Asthma (diagnoses ohter than nonallergic)

2160

10933

1.62

90.44

1.3

—

Exposure to unspecified factor

2489

10888

1.58

90.39

1.3

—

Colectomy operation

534

2103

2.66

90.19

1.5

1.3

—

Cholelithiasis, broad definition with cholecystitis

2080

8532

1.65

90.07

1.4

1.3

—

Disorders of lacrimal system

1201

6374

1.90

89.94

1.4

1.3

—

Arthropathies

2055

6282

1.67

89.84

1.3

—

Malignant neoplasm

1986

7041

1.68

89.84

1.5

1.2

—

Any mental disorder

2512

8009

1.59

89.37

1.3

—

Lumbar disc prolapse

1499

6312

1.79

89.29

1.3

—

Hypothyroidism and >3 levothyroxin purchases

548

1132

2.77

89.11

1.3

1.2

—

Hypothyroidism, levothyroxine purchases

548

1132

2.77

89.11

1.3

1.2

—

Heart failure and antihypertensive medication

609

1582

2.57

88.94

1.5

1.3

—

Hernia

2235

9351

1.61

88.60

1.3

—

Other/unspecified dorsalgia

944

4665

2.04

88.25

1.4

1.3

—

Malignant neoplasm

1980

7050

1.67

88.13

1.5

1.2

—

Other acute lower respiratory infections

1366

7333

1.81

87.76

1.5

1.3

—

Faecal incontinence

310

916

3.57

87.73

1.3

1.2

—

Asthma, hospital admissions 3, pneumonia

985

5012

2.01

87.34

1.4

1.3

—

Asthma-related pneumonia or sepsis

985

5012

2.01

87.34

1.4

1.3

—

Other CVD (FINNGEN)

356

837

3.39

87.20

1.4

1.3

—

Intestinal adhesions without obstruction

278

768

3.82

87.07

1.6

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1014

3189

2.04

86.94

1.4

1.3

—

Asthma-related pneumonia

982

5000

2.01

86.92

1.4

1.3

—

Endocrine, nutritional and metabolic diseases

1791

5317

1.72

86.90

1.3

—

Other dialysis

164

304

6.12

86.67

1.5

1.4

—

Fungal Sepsis

196

422

5.10

86.62

1.9

1.3

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

590

1639

2.55

86.33

1.4

1.3

—

Malignant neoplasm, including Hilmo

2007

7171

1.65

86.10

1.5

1.2

—

Other nutritional deficiencies

1683

9228

1.69

85.57

1.3

—

Malignant neoplasm, wide definition

2008

7183

1.65

85.55

1.5

1.2

—

Depression medications

615

1216

2.59

85.36

1.3

1.2

—

Cardiovascular diseases

1350

3908

1.86

85.35

1.3

—

Ulcerative ileocolitis

169

324

5.69

85.18

1.6

1.3

—

Urinary track infection

1463

4091

1.82

85.05

1.3

1.2

—

Neurological diseases, wide definition

607

1193

2.60

84.97

1.4

1.3

—

Cholelithiasis

1994

8434

1.64

84.93

1.3

—

Injuries to the head

2675

10457

1.54

84.81

1.3

—

Rotator cuff syndrome

1426

5568

1.79

84.56

1.3

—

Implicit fungal Sepsis

187

396

5.21

84.42

1.9

1.3

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

262

456

4.17

84.27

1.4

1.3

—

Hypokalaemia

402

1422

2.96

83.76

1.5

1.3

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2213

11044

1.58

83.62

1.3

—

Other and unspecified dermatitis

1331

7580

1.79

83.37

1.4

1.3

—

Spinal stenosis

1196

4780

1.88

83.36

1.3

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

456

1727

2.76

83.31

1.5

1.3

—

Non-selective monoamine reuptake inhibitors

926

4512

2.01

82.76

1.3

—

Fissure and fistula of anal and rectal regions

569

2393

2.44

82.52

1.4

1.3

—

Disorders of thyroid, IBD co-morbidities

382

852

3.14

82.00

1.3

—

Abnormal findings on diagnostic imaging of lung

1215

6406

1.83

81.69

1.5

1.3

—

Hypo-osmolality and hyponatraemia

523

2118

2.54

81.44

1.5

1.3

—

Sleep apnoea

2236

9039

1.58

81.25

1.3

—

Benign neoplasms

2256

7835

1.59

80.99

1.3

—

Psychiatric diseases

2191

6929

1.60

80.78

1.3

—

Cytomegalovirus infection, IBD co-morbidity

140

241

6.71

80.30

2.5

1.3

—

Bacterial pneumoniae

984

4501

1.96

80.20

1.4

1.2

—

Hypertensive diseases (excluding secondary)

1122

3448

1.92

80.20

1.3

—

Bacterial pneumonia, not elsewhere classified

943

4256

1.99

80.03

1.4

1.2

—

Other/unspecified cytomegaloviral diseases

134

223

7.10

79.92

2.5

1.3

—

Haemorrhage from respiratory passages

822

3566

2.08

79.79

1.3

—

Obesity due to excess calories

1217

6847

1.81

79.66

1.3

—

Other systemic involvement of connective tissue (FG)

701

3207

2.21

79.59

1.3

—

Neoplasms

1668

5187

1.71

79.41

1.4

1.2

—

Other gastritis (incl. Duodenitis)

592

2584

2.36

79.23

1.4

1.3

—

Systemic connective tissue disorders

954

4992

1.96

79.05

1.4

1.3

—

Hypertension, essential

1698

5763

1.69

78.62

1.3

—

Other diseases of hard tissues of teeth

1229

3458

1.87

78.39

1.3

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1232

6728

1.80

78.04

1.3

—

Heart failure, strict

1399

5634

1.76

77.49

1.4

1.3

—

Any event in cancer register

2092

7773

1.59

77.39

1.5

1.2

—

Immunodeficiency with predominantly antibody defects

145

267

6.16

77.21

2.8

1.3

—

Exposure to other specified factors

1950

10663

1.59

77.07

1.4

1.3

—

Inflammatory diseases of female pelvic organs

1612

6657

1.69

76.70

1.3

—

Chronic gastritis

689

3241

2.19

76.67

1.4

1.3

—

Failure and rejection of transplanted organs and tissues

104

138

9.15

76.64

4.8

1.3

—

Campylobacter enteritis

146

272

6.03

76.58

1.8

1.3

—

Sleep apnoea, including avohilmo

2343

9287

1.55

76.56

1.3

—

Cytomegaloviral disease, including avohilmo

143

264

6.21

76.17

2.4

1.3

—

Other arrhythmias

1501

6671

1.71

76.13

1.3

—

Diseases of the musculoskeletal system and connective tissue

1120

2977

1.91

76.10

1.3

—

All-cause Heart Failure

1379

5565

1.76

76.08

1.4

1.3

—

Vascular disorders of the intestines

223

581

4.06

76.03

1.6

1.2

—

Acute bronchitis

1045

5586

1.87

75.65

1.5

1.3

—

Sulfasalazine

680

3200

2.18

75.39

1.3

1.2

—

Cytomegaloviral disease

141

261

6.20

74.90

2.5

1.3

—

Other diseases of upper respiratory tract

2506

8664

1.52

74.86

1.3

—

Other diseases of blood and blood-forming organs, wide

630

2897

2.25

74.67

1.9

1.3

—

Personality disorders, excluding more controls

632

2896

2.23

74.47

1.3

—

Mycoses

773

3843

2.07

74.37

1.6

1.3

—

Unspecified kidney failure

327

1103

3.11

74.26

1.6

1.3

—

Heartburn

314

1033

3.16

74.14

1.4

1.3

—

Other arthrosis

1190

4454

1.82

73.90

1.3

—

Diseases of the ear and mastoid process

2609

8759

1.51

73.86

1.3

—

Missing teeth due to accident, extraction or parodontitis

1518

8247

1.67

73.36

1.4

1.3

—

Cardiovascular diseases (excluding rheumatic etc)

1378

4558

1.75

73.31

1.3

—

Multiple myeloma, including Hilmo

183

426

4.66

73.27

2.0

1.2

—

Falls/tendency to fall

2413

7979

1.53

73.22

1.3

—

Substance abuse, excluding more controls

1256

6058

1.76

72.68

1.4

1.3

—

Explicit bacterial Sepsis, including avohilmo

323

1095

3.08

72.52

1.5

1.3

—

Viral infections characterized by skin and mucous membrane lesions

1059

5888

1.83

71.98

1.4

1.3

—

Gout, FINNGEN

718

3489

2.10

71.94

1.5

1.3

—

Type 2 diabetes, wide definition

1808

7162

1.61

71.85

1.3

—

Diseases of liver

890

4701

1.94

71.65

1.4

1.3

—

Explicit bacterial Sepsis

314

1062

3.08

70.80

1.5

1.3

—

Malignant neoplasm of digestive organs, including Hilmo

1030

4134

1.87

70.53

1.4

1.2

—

Other specified/unspecified arthritis

663

3172

2.14

70.49

1.4

1.3

—

Visual disturbances and blindness

1306

7750

1.71

70.44

1.3

—

Urticaria and erythema

940

5079

1.89

70.39

1.4

1.3

—

Disease of hard tissues of teeth, NOS

1162

3376

1.83

69.58

1.3

—

Spondylosis

1219

5504

1.76

69.57

1.3

—

Disorders of synovium and tendon

1207

5932

1.75

69.12

1.3

—

Chronic lower respiratory diseases

2765

10035

1.47

68.75

1.3

—

Solid cancers, including Hilmo

1897

7071

1.58

68.63

1.4

1.2

—

Vocal cord dysfunction

313

927

3.05

68.50

1.4

1.3

—

Undetermined asthma, excluding more controls

350

1276

2.83

68.39

1.4

1.2

—

Hypertensive diseases

1689

5922

1.63

68.36

1.3

—

Hypertension

1688

5918

1.63

68.29

1.3

—

Hypothyroidism, strict autoimmune

1582

6408

1.64

67.97

1.3

—

Migraine without aura

534

2380

2.31

67.93

1.3

—

Disorders of mineral metabolism

283

927

3.22

67.85

1.6

1.3

—

Factors influencing health status and contact with health services

555

1167

2.42

67.79

1.3

1.2

—

Streptococcal septicaemia, including avohilmo

277

898

3.23

67.40

1.5

1.2

—

Enlarged lymph nodes

404

1596

2.61

67.35

1.7

1.2

—

Solid cancers

1846

6917

1.58

67.16

1.4

1.2

—

Chronic pancreatitis

358

1339

2.79

67.12

1.3

—

Other external causes of accidental injury

1758

5520

1.61

66.93

1.3

—

Cholecystectomy

1676

9049

1.60

66.91

1.3

—

Agranulocytosis

367

1397

2.76

66.79

2.1

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2181

9182

1.52

66.74

1.4

1.3

—

Chronic laryngitis and laryngotracheitis

411

1651

2.59

66.57

1.4

1.3

—

Disorders of lens

1478

5580

1.67

66.53

1.4

1.3

—

Other arthritis (FG)

755

3867

2.00

66.50

1.4

1.3

—

Candidiasis

441

1837

2.50

66.15

1.7

1.3

—

Streptococcal septicaemia

270

872

3.24

66.13

1.5

1.2

—

Bacterial pneumonia (organism specified)

1063

5474

1.79

65.96

1.4

1.3

—

Undetermined asthma

350

1303

2.77

65.71

1.4

1.2

—

Ulcerative enterocolitis

131

253

5.66

65.62

1.6

1.3

—

Pain and other conditions associated with female genital organs and menstrual cycle

546

2053

2.28

65.59

1.4

1.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

129

247

5.77

65.45

2.1

1.3

—

Multiple myeloma

129

247

5.77

65.45

2.1

1.3

—

Fitting and adjustment of other devices

882

4180

1.90

65.41

1.4

1.3

—

Obesity and other hyperalimentation

1527

9011

1.62

65.39

1.3

—

Migraine with aura

640

3111

2.11

65.20

1.3

—

Obesity

1520

8983

1.62

65.10

1.3

—

Other specified/unspecified bacterial intestinal infections

231

689

3.56

64.82

1.6

1.2

—

Nonhereditary hypogammaglobulinemia

109

9.57

64.59

3.2

1.3

—

Other CVD

553

2560

2.23

64.40

1.4

1.3

—

Symptoms and signs concerning food and fluid intake

303

1057

2.97

64.35

1.4

1.2

—

Hypothyroidism, drug reimbursement

298

680

3.14

64.23

1.3

1.2

—

Cerebrovascular diseases (FINNGEN)

672

2285

2.10

63.96

1.4

1.3

—

Dental operations

1274

3829

1.73

63.79

1.3

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1319

6265

1.68

63.57

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

651

3171

2.07

63.51

1.2

1.3

—

Disorders of calcium metabolism

231

701

3.50

63.09

1.5

1.3

—

Cervical disc disorders

824

4424

1.90

62.92

1.3

—

Diseases of arteries, arterioles and capillaries

1526

7024

1.62

62.87

1.3

—

Chronic sinusitis

994

5642

1.79

62.84

1.4

1.3

—

Fibromyalgia

292

1016

3.01

62.80

1.3

—

L04AC Interleukin inhibitors

230

701

3.48

62.35

1.5

1.4

—

Other diseases of lip and oral mucosa

1059

6152

1.76

62.26

1.4

1.3

—

Diseases of the eye and adnexa

1690

5351

1.60

62.22

1.3

—

Enteropathic arthropathies

114

205

6.18

61.97

1.4

—

Soft tissue disorders related to use, overuse and pressure

675

3411

2.03

61.91

1.3

—

Unspecified haematuria

972

4451

1.81

61.60

1.3

—

Intestinal malabsorption

182

480

4.08

61.59

1.5

1.3

—

Other abnormal uterine and vaginal bleeding

587

1981

2.19

61.47

1.3

—

Atrial fibrillation and flutter

665

2092

2.09

61.34

1.4

1.3

—

Disorders of other endocrine glands

1093

6325

1.73

61.19

1.4

1.3

—

Obesity related asthma

872

4823

1.85

60.74

1.3

—

Polyarthrosis

532

2216

2.22

60.74

1.4

1.3

—

Injuries to the ankle and foot

1690

9402

1.56

60.59

1.3

—

Arthrosis

1476

5006

1.64

60.44

1.3

—

Diseases of oral cavity, salivary glands and jaws

1167

3481

1.75

60.41

1.3

—

Other protozoal intestinal diseases, including avohilmo

108

189

6.33

60.35

1.4

1.2

—

Osteoporosis

725

3469

1.97

60.33

1.5

1.3

—

Antihypertensive medication - note that there are other indications

1297

4046

1.70

60.33

1.3

—

Visual disturbances

1185

7159

1.69

60.10

1.4

1.3

—

Chronic apical periodontitis

2537

9924

1.45

60.07

1.3

—

Ischemic heart diseases

1828

7128

1.55

60.01

1.3

—

Menorrhagia

792

2291

1.97

59.62

1.3

—

Gonarthrosis

1342

4607

1.67

59.58

1.3

—

Immunodeficiencies

185

506

3.94

59.51

2.5

1.3

—

Presence of cardiac and vascular implants and grafts

970

4033

1.80

59.27

1.3

1.2

—

Non-Hodgkin lymphoma, all, including Hilmo

355

1409

2.62

59.01

2.0

1.3

—

Excessive, frequent and irregular menstruation

899

2597

1.88

58.97

1.3

—

Gingivitis and periodontal diseases

2182

7641

1.49

58.82

1.3

—

Asthma, including avohilmo

2675

10410

1.43

58.72

1.3

—

Reimbursement for rheumatic diseases

1337

8313

1.62

58.71

1.3

—

Hernia of abdominal wall

1065

6304

1.72

58.40

1.4

1.3

—

Urticaria

757

4064

1.91

58.02

1.4

1.3

—

Other systemic involvement of connective tissue

720

3811

1.94

57.86

1.4

1.3

—

Hard cardiovascular diseases

1826

7123

1.53

57.72

1.3

—

Accidents

1708

5520

1.57

57.65

1.3

—

Diabetes, varying definitions

2271

9084

1.46

57.43

1.3

—

Rheumatism, unspecified

372

1530

2.52

57.33

1.4

1.3

—

Other viral diseases, including avohilmo

910

5129

1.79

57.25

1.6

1.3

—

Multiple myeloma and malignant plasma cell neoplasms

184

516

3.84

57.11

2.0

1.3

—

Fentanyl

279

993

2.91

57.09

1.6

1.3

—

Percutaneous Coronary Intervention

1730

6892

1.55

57.06

1.3

—

Type 2 diabetes

2187

8685

1.47

56.96

1.3

—

Viral pneumonia

355

1432

2.57

56.95

1.7

1.2

—

Cellulitis

577

2846

2.08

56.86

1.5

1.3

—

Hypotension

477

2191

2.25

56.76

1.4

1.3

—

Polycystic ovarian syndrome, consortium definition

1729

6491

1.55

56.75

1.3

—

Gastroduodenal ulcer

588

2911

2.06

56.57

1.4

1.3

—

Chronic rhinitis, nasopharyngitis and pharyngitis

779

4251

1.87

56.57

1.3

—

Rheumatoid arthritis

720

3370

1.93

56.51

1.3

—

Generalized anxiety disorder

426

1869

2.34

56.21

1.3

—

Diabetes mellitus

2272

9094

1.46

56.04

1.3

—

Early onset COPD, excluding more controls

427

1880

2.32

55.77

1.3

1.2

—

Other cataract

989

4263

1.75

55.46

1.3

—

Zoster [herpes zoster], including avohilmo

1236

7422

1.63

55.37

1.4

1.3

—

Disturbances of skin sensation

693

3673

1.93

55.35

1.3

—

External causes of morbidity and mortality

1350

4166

1.64

55.30

1.4

1.2

—

Gonarthrosis [arthrosis of knee](FG)

1579

5857

1.57

55.24

1.3

—

Polyneuropathies and other disorders of the peripheral nervous system

559

2761

2.08

55.02

1.5

1.3

—

Malignant neoplasm of digestive organs

897

3885

1.80

55.01

1.3

1.2

—

COPD (mode)

646

2578

1.99

54.46

1.4

1.2

—

Gout, idiopatic and unspecified

607

3100

2.01

54.27

1.4

1.3

—

Insulin medication

1355

7142

1.60

54.19

1.4

1.3

—

Behavioural syndromes associated with physiological disturbances and physical factors

2142

10057

1.46

54.15

1.3

—

Deforming dorsopathies

658

3450

1.95

54.12

1.3

—

Major coronary heart disease event

1838

7375

1.51

54.08

1.3

—

Other and unspecified disorders of skin and subcutaneous tissue

216

694

3.30

53.82

1.6

1.3

—

STROKE

1208

4993

1.65

53.62

1.4

1.3

—

Other disorders of ear

2034

9041

1.47

53.43

1.3

—

Ovarian cyst

801

2481

1.88

53.41

1.3

—

Coronary revascularization (ANGIO or CABG)

1711

6895

1.53

53.24

1.3

—

Senile cataract

1320

5026

1.62

53.02

1.3

—

Certain disorders involving the immune mechanism

494

2365

2.15

52.96

1.8

1.3

—

Injuries to the knee and lower leg

2669

10376

1.40

52.91

1.3

—

Ulcer of lower limb, not elsewhere classified

396

1738

2.36

52.75

1.4

1.3

—

Intracranial injury

1345

8032

1.58

52.70

1.3

—

Venous thromboembolism

1235

7486

1.61

52.69

1.4

1.3

—

Coxarthrosis

1052

4029

1.71

52.66

1.3

—

Somatoform disorder

430

1956

2.27

52.44

1.4

1.3

—

Other and unspecified polyneuropathies, also in other diseases

499

2408

2.14

52.40

1.5

1.3

—

Hyperkalaemia

190

576

3.48

51.90

1.6

1.3

—

Presence of other functional implants

1291

5566

1.61

51.88

1.4

1.2

—

Atrial fibrillation and flutter with reimbursement

541

1639

2.12

51.64

1.3

—

Ventral hernia

602

3120

1.98

51.59

1.4

1.3

—

Sleep disorders

2063

9887

1.45

51.58

1.2

1.3

—

Polyuria

547

2745

2.04

51.43

1.4

1.3

—

Nonorganic sleeping disorders, excluding more controls

495

2396

2.11

51.22

1.3

—

Emergency coronary revascularization (for ACS)

1848

7585

1.49

50.99

1.3

—

Impingement syndrome of shoulder

544

2733

2.04

50.90

1.4

1.3

—

Colorectal cancer, including Hilmo

628

3079

1.94

50.73

1.3

1.2

—

Insulin, intermediate and long-acting

1218

7455

1.60

50.27

1.4

1.3

—

Post-traumatic stress disorder

241

852

2.93

50.27

1.3

1.2

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

295

1162

2.65

50.14

2.6

1.3

—

Type 2 diabetes, definitions combined

2066

8372

1.45

49.85

1.3

—

Abnormal findings on examination of blood, without diagnosis

1050

5823

1.66

49.61

1.4

1.3

—

Type 2 diabetes, strict (exclude DM1)

2073

8423

1.45

49.33

1.3

—

Periodontitis

2199

9927

1.43

49.22

1.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1355

8006

1.56

49.21

1.4

1.3

—

Chronic periodontitis, including avohilmo

2196

9926

1.43

49.13

1.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

1327

8647

1.56

48.88

1.3

—

Disorders of adult personality and behaviour

672

3673

1.87

48.73

1.3

—

Coxibs

589

1539

2.04

48.71

1.3

—

Substance abuse

1256

7498

1.58

48.67

1.4

1.3

—

Cervicalgia

497

2458

2.07

48.61

1.2

1.3

—

Primary Sclerosing Cholangitis, IBD and UDCA required

166

5.99

48.59

1.9

1.2

—

Coxarthrosis [arthrosis of hip](FG)

1162

4993

1.62

48.40

1.3

—

Gout, unspecified

498

2472

2.07

48.39

1.5

1.3

—

Insomnia

2022

9881

1.44

48.20

1.2

1.3

—

Other and unspecified urticaria

505

2524

2.06

48.13

1.3

—

Benign neoplasm: Colon, unspecified

629

3390

1.90

47.96

1.4

1.3

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

458

2225

2.12

47.21

1.5

1.2

—

Gastric ulcer

422

1987

2.18

47.11

1.4

1.3

—

Mental and behavioural disorders due to psychoactive substance use

1285

7659

1.56

46.97

1.4

1.3

—

Meniscus derangement

1114

4596

1.63

46.90

1.2

1.3

—

All influenza (not pneumonia)

359

1587

2.33

46.85

1.5

1.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2027

8458

1.44

46.57

1.3

—

Presence of other devices

574

2977

1.94

46.54

1.3

1.2

—

Other salmonella infections, including avohilmo

134

346

4.09

46.52

1.7

1.2

—

Other viral diseases

678

3758

1.83

46.39

1.7

1.3

—

Migraine with aura and triptan purchases

416

1969

2.17

45.91

1.3

—

Kela reimbursement Agammaglobulinemia (D80-84)

8.94

45.79

3.3

1.3

—

Other and unspecified effects of external causes

657

3637

1.84

45.77

1.3

—

Personality disorders

632

3458

1.87

45.74

1.3

—

Diabetes medication

2270

9551

1.40

45.36

1.3

—

Non-ischemic cardiomyopathy

716

3197

1.81

45.35

1.4

1.3

—

Colorectal cancer

555

2798

1.95

45.26

1.3

1.2

—

Internal derangement of knee

773

4447

1.75

45.23

1.3

—

Diseases of inner ear

1236

7711

1.56

45.23

1.3

—

Retention of urine

741

3411

1.79

45.19

1.4

1.3

—

Endometriosis

741

2406

1.82

45.07

1.3

—

Iron deficiency anaemia secondary to blood loss (chronic)

418

1999

2.15

45.01

1.5

1.3

—

Conductive and sensorineural hearing loss

1697

7752

1.47

44.90

1.3

—

Panic disorder

362

1636

2.27

44.81

1.3

—

Diseases of pulp and periapical tissues, including avohilmo

2264

8415

1.40

44.78

1.3

—

Sensorineural hearing loss

1626

7403

1.48

44.76

1.3

—

Conjunctivitis (acute, non atopic), including avohilmo

2225

9679

1.40

44.74

1.3

—

Other enthesopathies

651

3617

1.83

44.65

1.3

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

946

5742

1.65

44.49

1.4

1.3

—

Paracetamol or NSAID medication

319

634

2.58

44.48

1.3

—

Heart failure and bmi 25plus

792

3053

1.76

44.33

1.4

1.3

—

Spondyloarthritis

405

1921

2.16

44.31

1.4

1.3

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

551

2920

1.93

44.28

1.4

1.2

—

Emotionally unstable personality disorder

318

1370

2.39

44.22

1.3

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

259

1020

2.64

44.02

1.4

1.2

—

Injuries to the shoulder and upper arm

1897

10369

1.43

43.87

1.3

—

Artrosis, including avohilmo

1690

6347

1.47

43.69

1.3

—

ILD, hospital admission 2, with pulmonary infections

244

938

2.69

43.39

1.5

1.2

—

Other symptoms and signs involving the circulatory and respiratory systems

194

662

3.06

43.35

1.4

1.3

—

Disorders of vestibular function (Vertigo)

1081

6736

1.59

43.30

1.3

—

Convulsions, not elsewhere classified

475

2374

2.01

43.29

1.3

1.2

—

Donors of organs and tissues

142

6.24

43.18

2.7

1.2

—

Temporomandibular joint disorders, including avohilmo

1047

6442

1.60

43.15

1.3

—

Other symptoms and signs involving cognitive functions and awareness

1036

5801

1.61

43.13

1.3

—

Type 2 diabetes, definitions combined, including avohilmo

2034

8394

1.41

42.87

1.3

—

Gout, strict definition

439

2184

2.07

42.51

1.5

1.3

—

Subjective visual disturbances

636

3571

1.82

42.45

1.3

—

Vasomotor and allergic rhinitis

824

4842

1.69

42.45

1.4

1.3

—

Asthma, hospital admissions , main diagnosis only

1801

11104

1.42

42.30

1.3

—

Anaemia in chronic diseases classified elsewhere

101

229

4.81

42.10

1.7

1.3

—

DVT of lower extremities and pulmonary embolism

936

5815

1.63

41.87

1.5

1.3

—

Migraine without aura and triptan purchases

412

2013

2.10

41.81

1.3

—

Disorders of skin appendages

1131

7332

1.56

41.77

1.3

—

Cutaneous abscess, furuncle and carbuncle

611

3404

1.83

41.75

1.4

1.3

—

Other and unspecified tonsillitis

691

3283

1.78

41.67

1.4

1.3

—

Disorders of the thyroid gland

2044

9553

1.40

41.65

1.3

—

Injuries to the thorax

1023

6521

1.59

41.62

1.4

1.3

—

Localized swelling, mass and lump of skin and subcutaneous tissue

740

4360

1.73

41.55

1.4

1.3

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

477

2462

1.99

41.54

1.3

—

Persistent mood disorders

468

2399

2.00

41.52

1.3

—

Asthma/COPD (KELA code 203)

2075

10030

1.39

41.49

1.3

—

Infections with a predominantly sexual mode of transmission, including avohilmo

897

5064

1.64

41.36

1.3

—

Diabetes, insulin treatment (Kela reimbursement)

2147

9272

1.39

41.26

1.3

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

369

1740

2.18

41.24

1.7

1.3

—

Disorders resulting from impaired renal tubular function

135

384

3.78

41.15

1.7

1.3

—

Unspecified fall

1164

7513

1.54

41.14

1.4

1.3

—

Other and unspecified nerve root and plexus disorders, also in other diseases

502

2644

1.94

41.11

1.3

—

Cholangitis (primary sclerosing, PSC)

188

651

3.03

41.08

1.6

1.3

—

Bipolar affective disorders

427

2130

2.05

40.87

1.3

—

Specific personality disorders

538

2903

1.89

40.79

1.3

—

Arthropathy in ulcerative colitis

129

6.45

40.79

1.5

1.3

—

Substance use, excluding alcohol

467

2410

1.98

40.61

1.5

1.3

—

Hypothyroidism, other/unspecified

1917

9031

1.41

40.50

1.3

—

Valvular heart disease excluding rheumatic fever

968

4325

1.62

40.45

1.3

—

Non-rheumatic valve diseases

964

4300

1.62

40.43

1.3

—

Poisoning by drugs, medicaments and biological substances

548

2985

1.87

40.34

1.3

—

Injury, poisoning and certain other consequences of external causes

1058

3330

1.61

40.28

1.3

1.2

—

Diseases of pulp and periapical tissues and dental caries

1329

4522

1.52

39.99

1.3

—

Disorders of conjunctiva

1856

10321

1.41

39.92

1.3

—

Heart failure and coronary heart disease

924

4018

1.64

39.85

1.4

1.3

—

Amputation

261

1080

2.50

39.85

1.4

1.3

—

Acute myeloid leukaemia and myelodysplastic syndromes

187

5.08

39.54

3.6

1.2

—

Ischaemic heart disease, wide definition

1609

6901

1.45

39.43

1.3

—

Acute pancreatitis

454

2349

1.98

39.23

1.4

1.3

—

Adrenocortical insufficiency

135

397

3.64

39.11

1.6

1.4

—

Dental caries, including avohilmo

1478

5161

1.48

38.90

1.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1985

9435

1.39

38.90

1.3

—

Drug-induced neutropenia

219

849

2.71

38.74

1.9

1.3

—

Deviated nasal septum

677

3964

1.73

38.65

1.3

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

729

4364

1.70

38.62

1.4

1.3

—

Infections with a predominantly sexual mode of transmission

682

4002

1.73

38.51

1.3

—

Other disorders of adrenal gland

151

481

3.32

38.33

1.5

1.3

—

Zoster [herpes zoster]

468

2472

1.94

38.14

1.5

1.3

—

Non-follicular lymphoma

260

1100

2.46

38.02

2.0

1.3

—

Diseases of peritoneum

267

1142

2.42

38.00

1.5

1.3

—

Vascular diseases of the intestine

133

394

3.58

37.93

1.7

1.3

—

Oxicams

460

1316

2.02

37.86

1.3

—

Transport accidents

954

5066

1.59

37.61

1.4

1.3

—

Hyperlipidaemia, other/unspecified

807

4465

1.65

37.57

1.3

—

Dentofacial anomalies [including malocclusion]

1544

8496

1.44

37.47

1.3

—

Colorectal adenocarcinoma

453

2348

1.95

37.35

1.3

1.2

—

Other (not insulin) diabetes medications

2072

8919

1.38

37.29

1.3

—

Insulin, fast-acting

786

4836

1.65

37.26

1.4

1.3

—

Hallux valgus (acquired)

702

2958

1.72

37.17

1.3

—

Misadventures to patients during surgical and medical care

359

1745

2.12

37.15

1.4

1.3

—

Other complications of surgical and medical care, not elsewhere classified

260

1110

2.42

37.13

1.5

1.2

—

Other diseases of liver

447

2347

1.95

37.10

1.4

1.3

—

ILD, hospital admissions 3, with pneumonia sepsis

220

870

2.62

37.09

1.5

1.2

—

Gonarthrosis,primary

1868

8140

1.40

37.08

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

651

3822

1.73

37.07

1.2

1.3

—

Sequelae of external causes of morbidity and mortality

614

3553

1.76

36.99

1.4

1.3

—

Other and unspecified drugs and medicaments

245

1022

2.50

36.99

1.5

1.3

—

Other neurological diseases

1539

8407

1.43

36.99

1.3

—

Postprocedural disorders of digestive system, not elsewhere classified

119

334

3.81

36.97

1.8

1.4

—

Poisoning by medicine

493

2672

1.88

36.95

1.3

—

Pain associated with micturition

323

1513

2.20

36.91

1.5

1.3

—

Chronic ulcer of skin, not elsewhere classified

195

733

2.78

36.54

1.4

1.3

—

Superficial injury of lower leg

623

3630

1.75

36.53

1.4

1.3

—

Caries of dentine, including avohilmo

1587

5682

1.44

36.38

1.3

—

Hypocalcemia

103

266

4.24

36.36

1.6

1.4

—

Stomatitis and related lesions

483

2621

1.89

36.16

1.4

1.3

—

Striking against or struck by other objects

739

4509

1.66

36.08

1.3

—

Allergic asthma (mode), excluding more controls

443

2276

1.93

35.92

1.3

1.2

—

Conjunctivitis (acute, non atopic)

649

3826

1.72

35.83

1.4

1.3

—

Acute pharyngitis

329

1548

2.15

35.83

1.4

1.3

—

Other viral diseases, not elsewhere classified, including avohilmo

593

3406

1.76

35.69

1.4

1.3

—

Conduction disorders

631

2945

1.75

35.60

1.3

—

Diseases of external ear

795

4971

1.63

35.45

1.4

1.3

—

Colonic or urogenital fistula

614

3596

1.74

35.41

1.4

1.3

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

347

1697

2.10

35.35

1.4

1.3

—

333

1603

2.13

35.28

1.3

—

Chronic diseases of tonsils and adenoids

1606

7204

1.42

35.27

1.3

—

UC patients in KELA-register (code 208), prior to 1994

134

418

3.40

35.26

1.4

1.3

—

Peripheral artery disease

911

4613

1.58

35.13

1.4

1.3

—

Malignant neoplasm of colon, including Hilmo

413

2142

1.96

35.01

1.3

1.2

—

Allergic asthma (mode)

444

2305

1.91

34.91

1.3

1.2

—

Hyperkinetic disorders, excluding more controls

273

1131

2.30

34.79

1.2

—

Fracture of rib(s), sternum and thoracic spine

681

4124

1.68

34.58

1.4

1.3

—

Glomerulonephritis

247

1065

2.40

34.55

1.4

1.3

—

Hydronephrosis

271

1214

2.30

34.51

1.4

1.3

—

Any operation in hilmo

7.99

34.51

1.3

1.1

—

Decubitus ulcer and pressure area

178

658

2.82

34.49

1.5

1.3

—

Enthesopathies of lower limb, excluding foot

491

2716

1.84

34.42

1.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

845

5321

1.59

34.42

1.3

—

Convalescence

156

539

3.03

34.32

1.4

1.2

—

Caries of enamel

2055

10009

1.35

34.31

1.3

—

Carpal tunnel syndrome

1298

7815

1.46

34.27

1.3

—

Other retinal disorders

1371

7288

1.44

34.18

1.3

—

Ascites

178

660

2.79

34.13

1.6

1.2

—

Open wound of head

1148

7341

1.49

34.08

1.3

—

Disorders of sclera, cornea, iris and ciliary body

1190

8181

1.47

34.04

1.3

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

221

915

2.51

33.98

1.5

1.3

—

Acute peritonitis

176

653

2.81

33.89

1.5

1.3

—

Adverse effects, not elsewhere classified

464

2538

1.87

33.89

1.3

—

Coagulation defects, purpura and other haemorrhagic conditions

461

2517

1.87

33.88

1.8

1.3

—

Acute pancreatitis (for exclusion)

454

2468

1.88

33.82

1.4

1.3

—

Other extrapyramidal and movement disorders in other diseases

587

3442

1.74

33.81

1.3

—

Other infectious diseases, including avohilmo

234

995

2.43

33.79

1.7

1.3

—

Insulin, fast-acting or short human

791

4995

1.61

33.74

1.4

1.3

—

Injuries to the wrist and hand

2179

10880

1.34

33.71

1.3

—

Purpura and other haemorrhagic conditions

334

1641

2.09

33.64

2.1

1.3

—

Paroxysmal tachycardia

442

1959

1.91

33.58

1.3

—

Neuromuscular dysfunction of bladder

229

967

2.45

33.57

1.4

1.3

—

Drug-induced cataract

255

4.14

33.38

1.7

1.3

—

Conjunctivitis

1660

9719

1.39

33.31

1.3

—

Other shoulder lesions

233

995

2.41

33.22

1.3

—

Trochanteric bursitis

348

1747

2.04

32.96

1.3

—

Primary gonarthrosis, bilateral

1118

6367

1.49

32.96

1.3

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

675

4140

1.66

32.65

1.3

—

Glucagon-like peptide-1 (GLP-1) analogues

675

4140

1.66

32.65

1.3

—

Arthropathies in other diseases classified elsewhere

109

313

3.68

32.62

1.4

1.3

—

Type of accident

662

4042

1.67

32.60

1.3

—

Disorders of parathyroid gland

499

2790

1.81

32.60

1.4

1.3

—

Atopic dermatitis

1253

6940

1.45

32.48

1.3

—

Excessive attrition of teeth

1306

9116

1.43

32.40

1.3

—

Peripheral artery operations in Hilmo

293

1391

2.16

32.23

1.4

1.3

—

Other diseases of pleura

936

5371

1.53

32.08

1.4

1.3

—

Nonorganic sleeping disorders

495

2812

1.80

31.86

1.3

—

Amputation of toe

185

726

2.65

31.84

1.4

1.3

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

420

1197

1.96

31.70

1.2

1.4

—

Diffuse large B-cell lymphoma

143

493

3.05

31.70

1.9

1.2

—

Diffuse large B-cell lymphoma, including Hilmo

143

493

3.05

31.70

1.9

1.2

—

Diffuse large B-cell lymphoma, helper endpoint

143

493

3.05

31.70

1.9

1.2

—

Disorders of choroid and retina

1673

8570

1.38

31.67

1.3

—

Unspecified urinary incontinence

257

1172

2.28

31.65

1.4

1.3

—

Osteoporosis with pathological fracture (FG)

207

860

2.51

31.63

1.5

1.3

—

Spondylopathies (FG)

306

1488

2.11

31.61

1.5

1.3

—

Other and unspecified local infections of skin and subcutaneous tissue

248

1114

2.30

31.52

1.4

1.3

—

Fibrosis and cirrhosis of liver

211

887

2.47

31.41

1.6

1.3

—

Atherosclerosis, excluding cerebral and coronary sclerosis

846

4301

1.57

31.33

1.3

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

370

1932

1.96

31.25

1.3

—

Osteomyelitis

172

659

2.72

31.11

1.4

1.3

—

Benign neoplasm: Caecum

285

1365

2.16

30.97

1.4

1.3

—

Other local infections of skin and subcutaneous tissue

258

1189

2.24

30.79

1.4

1.3

—

Pneumonia due to other infectious organisms, not elsewhere classified

110

331

3.53

30.74

2.0

1.3

—

Hyperplasia of prostate

614

2046

1.71

30.50

1.3

1.4

—

Abscess of anal and rectal regions

178

698

2.62

30.47

1.4

1.3

—

Pulmonary heart disease, diseases of pulmonary circulation

689

4320

1.62

30.46

1.5

1.3

—

Paralytic ileus

274

3.74

30.43

1.8

1.3

—

Extrapyramidal and movement disorders

842

5529

1.55

30.38

1.3

—

Artificial joint operation, meniscal resection

1867

8934

1.35

30.16

1.3

—

Non-Hodgkin lymphoma, all

124

405

3.21

30.15

2.7

1.3

—

Other protozoal intestinal diseases

124

5.48

30.09

1.5

1.3

—

Diabetic nephropathy, excluding more controls

363

1538

1.98

30.09

1.4

1.2

—

Phlebitis and thrombophlebitis (not including DVT)

503

2920

1.76

30.06

1.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

580

3454

1.69

29.98

1.4

1.3

—

Diseases of male genital organs

855

2764

1.57

29.90

1.3

—

Weight loss

267

1264

2.18

29.87

1.4

1.3

—

Coronary atherosclerosis

1295

5767

1.43

29.86

1.3

—

Other infectious diseases

195

810

2.50

29.76

1.8

1.3

—

Other skin changes

465

2650

1.79

29.73

1.5

1.3

—

Erosion of teeth , including avohilmo

590

3583

1.67

29.72

1.3

—

Pruritus

296

1459

2.09

29.65

1.5

1.3

—

Secondary and unspecified malignant neoplasm of lymph nodes

204

869

2.43

29.39

2.0

1.3

—

Other problems related to primary support group, including family circumstances

259

1181

2.19

29.37

1.5

1.3

—

Inflammatory disease of uterus

329

1689

2.00

29.32

1.3

—

Secondary uncertain malignant neoplasm

293

1443

2.08

29.31

1.9

1.3

—

Artificial opening status

144

520

2.89

29.25

1.5

1.3

—

Other inflammation of eyelid, including avohilmo

962

6539

1.49

29.25

1.4

1.3

—

Selective deficiency of immunoglobulin G [IgG] subclasses

7.56

29.25

3.6

1.4

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1761

8831

1.35

29.19

1.3

—

Cirrhosis of liver, NAS

152

567

2.81

29.10

1.6

1.4

—

Benign paroxysmal vertigo

665

4186

1.62

29.06

1.3

—

Recurrent aphthous stomatitis , including avohilmo

357

1891

1.94

29.03

1.3

—

Mental and behavioural disorders due to tobacco

216

950

2.35

28.94

1.5

1.3

—

Hypertensive heart and/or renal disease

524

2236

1.74

28.90

1.4

1.3

—

Abnormal weight loss

247

1150

2.22

28.87

1.4

1.3

—

Endometriosis of pelvic peritoneum

341

1609

1.97

28.84

1.3

—

1144

7170

1.44

28.80

1.3

—

Enteritis due to Yersinia enterocolitica

9.02

28.64

1.7

1.4

—

Smoking dependency

216

955

2.34

28.60

1.5

1.3

—

Other and unspecified immunodeficiencies with predominantly antibody defects

123

5.45

28.51

2.9

1.3

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

201

4.28

28.50

1.8

1.3

—

Unspecified acute lower respiratory infection

336

1756

1.96

28.35

1.5

1.3

—

Suicide or other Intentional self-harm

520

3096

1.71

28.31

1.3

—

Pulmonary embolism

634

3968

1.62

28.31

1.5

1.3

—

Other diseases of biliary tract

221

991

2.30

28.29

1.5

1.3

—

Abnormal findings on diagnostic imaging of other body structures

355

1894

1.92

28.28

1.3

—

Peripheral arterial reconstruction

367

1977

1.90

28.25

1.4

1.3

—

Other hammer toe(s) (acquired)

374

1834

1.89

28.22

1.3

—

Pulmonary heart disease

634

3972

1.62

28.19

1.5

1.3

—

Alcohol use disorder, Swedish definition

1072

6789

1.45

28.18

1.3

—

Irregular menses

1033

5344

1.47

28.15

1.3

—

Leisure time condition

421

2370

1.81

28.10

1.3

—

Mental and behavioural disorders due to alcohol

1000

6568

1.47

27.97

1.3

—

Special screening examination for other diseases and disorders

236

1087

2.21

27.95

1.3

1.2

—

Sequelae with surgical and medical care as external cause

467

2715

1.76

27.89

1.4

1.3

—

Herpesviral [herpes simplex] infections, including avohilmo

570

3491

1.66

27.83

1.3

—

Injuries to the hip and thigh

1028

6392

1.46

27.74

1.4

1.3

—

Acute myeloid leukaemia

107

5.64

27.56

3.9

1.2

—

Acute myeloid leukaemia, helper endpoint

107

5.64

27.56

3.9

1.2

—

Acute myeloid leukaemia, including Hilmo

107

5.64

27.56

3.9

1.2

—

Psoriatic and enteropathic arthropathies

263

1276

2.11

27.47

1.3

—

Pain in thoracic spine

335

1768

1.93

27.44

1.4

1.3

—

Malignant neoplasm of rectum

222

1009

2.26

27.43

1.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

884

5989

1.49

27.41

1.3

—

Other disorders of bone

432

2469

1.78

27.34

1.4

1.3

—

Fenamates

300

1011

2.06

27.34

1.3

—

Varicose veins

1241

6709

1.41

27.33

1.3

—

Benign neoplasm: Transverse colon

271

1336

2.09

27.28

1.3

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

865

5786

1.50

27.26

1.3

—

Malignant neoplasm of rectum, including Hilmo

262

1273

2.11

27.25

1.3

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

496

2853

1.72

27.24

1.4

1.2

—

Otitis externa

508

3040

1.70

27.20

1.4

1.3

—

Exclusions for E4_PCOS_BROAD

385

2129

1.85

27.19

1.4

1.3

—

Chronic periodontitis, complicated

1168

8131

1.42

27.06

1.4

1.3

—

Triptan medication for migraine, single purchase ok

1573

7914

1.36

27.02

1.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1573

7914

1.36

27.02

1.3

—

Other disorders of kidney and ureter

309

1601

1.98

26.94

1.5

1.3

—

Asthma and allergy

251

1186

2.13

26.90

1.3

1.2

—

Other diseases of stomach and duodenum

165

667

2.57

26.76

1.6

1.3

—

1189

7403

1.41

26.70

1.3

—

Fibroblastic disorders

452

2637

1.74

26.50

1.3

—

Other and unspecified mood [affective] disorders

172

711

2.49

26.48

1.3

—

Coeliac disease

283

1431

2.03

26.44

1.3

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

456

2315

1.74

26.32

1.2

1.3

—

Diseases of the myoneural junction and muscle

285

1448

2.02

26.28

1.4

1.3

—

Alcohol use disorder, ICD-based

803

5384

1.51

26.23

1.3

—

Pollen allergy

401

2239

1.80

26.10

1.4

1.3

—

Alcohol abuse, main dg, excluding more controls

296

1526

1.98

26.00

1.3

—

Disorders of oesophagus in diseases classified elsewhere

196

4.10

25.97

1.8

1.3

—

Reactive arthropathies

199

886

2.31

25.89

1.3

1.4

—

Colitis, primary sclerosing

150

4.70

25.82

2.0

1.3

—

Viral pneumonia (known virus, not influenza)

302

3.42

25.80

1.9

1.3

—

Asthma and allergy, excluding more controls

250

1200

2.09

25.75

1.3

1.2

—

Cervicocranial syndrome

253

1241

2.09

25.71

1.2

1.3

—

Rheumatoid arthritis, including avohilmo

806

5436

1.50

25.70

1.3

—

Hyperparathyroidism

429

2465

1.76

25.69

1.4

1.3

—

Postmenopausal bleeding

542

1698

1.70

25.66

1.3

—

Superficial injury of head

531

3258

1.65

25.65

1.3

—

Acetic acid derivatives and related substances

498

1501

1.73

25.60

1.3

—

Other salmonella infections

287

3.43

25.58

1.8

1.2

—

Female genital prolapse

574

1950

1.66

25.43

1.2

1.3

—

Malignant neoplasm of colon

327

1757

1.90

25.42

1.3

—

Unspecified/other endometriosis

210

942

2.24

25.36

1.4

1.3

—

Superficial injury of ankle and foot

276

1403

2.01

25.34

1.3

—

KRA_PSY_EATING, excluding more controls

181

772

2.38

25.32

1.4

1.2

—

Obesity, other/unspecified

704

4630

1.54

25.29

1.3

—

Exclusions for E4_PCOS_CONSORTIUM

1517

7055

1.35

25.26

1.3

—

Spondylolisthesis/Spondylolysis

383

2164

1.80

25.25

1.3

—

Biguanides

1938

9022

1.31

25.10

1.3

—

Viral hepatitis, IBD co-morbidity

314

3.23

25.08

1.1

1.3

—

Other bursopathies

287

1485

1.98

25.06

1.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

433

2544

1.73

24.84

1.3

—

Unknown and unspecified causes of morbidity

151

606

2.56

24.77

1.3

1.2

—

Persons with potential health hazards related to communicable diseases

760

5055

1.51

24.69

1.3

—

Diabetic nephropathy

366

2032

1.82

24.67

1.4

1.3

—

Gonarthrosis, primary, with knee surgery

1184

6670

1.40

24.65

1.3

—

Colitis, primary sclerosing, strict definition

103

5.50

24.64

2.0

1.3

—

Other disorders involving the immune mechanism, not elsewhere classified

300

3.34

24.62

1.5

1.3

—

IBD (strict) with PSC

5.82

24.59

1.8

1.3

—

Seropositive rheumatoid arthritis

505

3081

1.66

24.53

1.3

—

Other viral diseases, not elsewhere classified

384

2183

1.79

24.49

1.5

1.3

—

Other disorders of veins

858

5816

1.47

24.46

1.4

1.3

—

Cerebrovascular diseases

1472

7630

1.35

24.44

1.3

—

Rare circulating lymphoid malignancy, including Hilmo

237

3.64

24.38

2.5

1.2

—

Scoliosis

205

948

2.22

24.36

1.3

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

220

1046

2.16

24.31

1.3

—

Other disorders of bladder

257

1295

2.03

24.27

1.4

1.3

—

Nephrotic syndrome

309

3.29

24.15

1.4

1.3

—

Myeloid leukaemia

279

3.43

24.14

3.4

1.3

—

Later onset COPD, excluding more controls

393

1704

1.79

24.14

1.4

1.2

—

Methotrexate

288

1511

1.95

24.12

1.3

1.2

—

Allergic rhinitis

640

4113

1.56

24.08

1.4

1.3

—

Thrombocytopenia, unspecified

179

788

2.35

24.06

2.3

1.3

—

Disorders of tooth development and eruption

318

1385

1.90

24.04

1.3

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

285

3.38

23.94

1.5

1.3

—

Follow-up examination after treatment for malignant neoplasms

194

882

2.25

23.92

1.4

1.2

—

Idiopathic gout

212

1005

2.17

23.70

1.5

1.4

—

Problems related to lifestyle

225

1089

2.11

23.69

1.3

—

Injuries to the neck

484

2967

1.66

23.64

1.3

—

Epilepsy

586

3746

1.58

23.58

1.4

1.3

—

Any death

1301

6720

1.37

23.55

1.6

1.3

—

AV-block

363

1747

1.80

23.52

1.3

—

Angina pectoris

1098

5229

1.41

23.41

1.3

—

Polymyalgia rheumatica

315

1722

1.88

23.36

1.4

1.3

—

COPD

878

4954

1.46

23.27

1.4

1.3

—

Need for other prophylactic measures

147

603

2.53

23.22

1.5

1.3

—

Disorders of continuity of bone

239

1195

2.05

23.15

1.4

1.3

—

Phobic anxiety disorders

269

1394

1.96

23.14

1.2

1.3

—

Reactive arthropathies, FINNGEN

162

694

2.41

23.14

1.3

—

Noninflammatory disorders of female genital tract

777

2600

1.52

23.13

1.3

—

Other diseases of arteries and capillaries

215

1035

2.14

23.10

1.3

—

Pneumocystosis

214

3.80

23.07

1.9

1.3

—

Pneumocystosis, including avohilmo

214

3.80

23.07

1.9

1.3

—

Orthopaedic devices associated with adverse incidents

200

3.91

23.05

1.5

1.3

—

Other female pelvic inflammatory diseases

361

2067

1.79

22.91

1.4

1.3

—

Diseases of middle ear and mastoid

1171

7000

1.38

22.88

1.4

1.3

—

Barrett oesophagus

124

472

2.73

22.86

1.4

1.3

—

Vitamin B12 deficiency anaemia

233

1160

2.06

22.80

1.5

1.3

—

SLE (Finngen)

319

3.15

22.80

1.4

1.3

—

Transient ischemic attack

1044

5978

1.41

22.77

1.3

—

therapeutic use

315

3.19

22.75

1.4

1.3

—

Fracture of lumbar spine and pelvis

490

3037

1.64

22.72

1.4

1.3

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

208

995

2.14

22.66

1.3

—

Plantar fascial fibromatosis

217

1055

2.11

22.65

1.3

—

Other disorders of patella

335

1882

1.81

22.54

1.3

—

Viral warts

226

1120

2.07

22.43

1.4

1.3

—

DVT of lower extremities

398

2354

1.72

22.40

1.4

1.3

—

Suppurative and unspecified otitis media

730

4382

1.49

22.29

1.4

1.3

—

Dermatophytosis, including avohilmo

1315

9677

1.34

22.24

1.3

—

Major coronary heart disease event excluding revascularizations

1167

5634

1.38

22.18

1.3

—

Triptan medication for migraine, min. 3 purchases

1151

6304

1.38

22.08

1.3

—

Other chronic obstructive pulmonary disease

841

4794

1.45

22.06

1.4

1.3

—

Other and unspecified myopathies

203

974

2.14

22.04

1.5

1.3

—

Cervicobrachial syndrome

429

2597

1.68

22.02

1.2

1.3

—

Protozoal diseases, including avohilmo

100

349

3.04

21.96

1.8

1.3

—

Herpesviral [herpes simplex] infections

268

1421

1.93

21.88

1.5

1.3

—

Other disorders of penis

192

903

2.17

21.77

1.3

1.4

—

Acute suppurative otitis media

531

3156

1.59

21.75

1.4

1.3

—

Disorders of vitreous body and globe

1059

7303

1.39

21.74

1.3

—

Restless leg syndrome

336

1915

1.80

21.72

1.3

—

Protozoal diseases

335

3.07

21.72

1.8

1.3

—

Benign neoplasm: Ascending colon

326

1846

1.81

21.58

1.3

—

Papulosquamous disorders

804

5612

1.45

21.53

1.3

—

Fracture of foot, except ankle

515

3280

1.59

21.52

1.3

—

Diabetic maculopathy, excluding more controls

233

1186

2.01

21.44

1.4

—

Cystic kidney disease

327

3.06

21.32

1.6

1.3

—

FESS (DNB20)

274

1478

1.90

21.22

1.4

1.3

—

Diseases of salivary glands

688

4677

1.49

21.21

1.3

—

Bitten or struck by other mammals

258

1366

1.93

21.15

1.4

1.3

—

Endocarditis

345

2.97

21.04

1.4

1.3

—

Myelodysplastic syndrome, including Hilmo

266

3.27

21.00

3.1

1.2

—

Drug-induced adrenocortical insufficiency

208

3.68

20.98

1.6

1.3

—

Other diseases of pericardium

117

454

2.68

20.81

1.3

—

Disorders of vitreous body

1031

7177

1.38

20.77

1.3

—

Nonalcoholic fatty liver disease

227

1160

2.01

20.73

1.3

—

Umbilical hernia

525

3388

1.57

20.71

1.4

1.3

—

Ankylosing spondylitis

184

870

2.17

20.71

1.5

1.3

—

Oesophageal varices

108

404

2.79

20.70

1.5

1.4

—

Visual impairment including blindness (binocular or monocular)

169

776

2.25

20.58

1.3

—

Hypercalcemia

126

511

2.58

20.58

1.4

1.3

—

Use of pramipexole

475

3006

1.61

20.53

1.3

—

Other disorders of eye and adnexa

320

1828

1.79

20.51

1.3

—

Inflammatory diseases of prostate (prostatitis)

225

1150

1.99

20.41

1.3

—

Moderate visual impairment, binocular

303

3.08

20.34

1.4

1.3

—

Polyp of the female genital tract

569

2081

1.57

20.26

1.3

—

845

5400

1.42

20.23

1.3

—

Other sleep disorders

243

1281

1.94

20.19

1.3

—

Propionic acid derivatives

505

1584

1.62

20.18

1.3

—

Cystic kidney disease, including avohilmo

354

2.90

20.14

1.6

1.3

—

Volvulus

207

3.53

20.12

1.6

1.3

—

Benign neoplasm: Rectum, anus and anal canal

427

2649

1.64

20.07

1.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified

350

2062

1.73

20.03

1.2

1.3

—

Colon adenocarcinoma

251

1341

1.91

20.01

1.2

1.3

—

Ethmoidectomy

278

1537

1.85

19.92

1.4

1.3

—

Myocardial infarction

925

4644

1.41

19.91

1.3

—

Hypertensive Heart Disease

446

2099

1.63

19.89

1.4

1.3

—

Superficial injury of wrist and hand

436

2722

1.63

19.88

1.3

—

Benign neoplasm: Sigmoid colon

408

2511

1.66

19.83

1.4

1.3

—

Mixed and other personality disorders

176

834

2.17

19.77

1.3

—

Other follicular disorders

170

795

2.20

19.76

1.4

1.3

—

Other necrotizing vasculopathies

177

843

2.17

19.73

1.5

1.3

—

Vitamin deficiency, wide

125

514

2.52

19.72

1.4

1.3

—

Vitamin deficiency

125

514

2.52

19.72

1.4

1.3

—

Other diseases of oesophagus

197

974

2.07

19.71

1.4

1.3

—

Diagnoses used for exclusion with ILD

507

3285

1.57

19.70

1.3

—

Ocular pain

203

1017

2.05

19.67

1.4

1.3

—

Open wound of wrist and hand

870

6039

1.40

19.63

1.3

—

Otalgia

202

1012

2.05

19.57

1.5

1.3

—

Unspecified mental disorder

783

5537

1.43

19.49

1.3

—

Other respiratory diseases principally affecting the interstitium

372

2247

1.69

19.44

1.5

1.3

—

Drug-induced osteoporosis with pathological fracture

190

3.71

19.35

1.8

1.3

—

Charcot foot

175

3.79

19.32

1.5

1.3

—

Disorders of breast

1032

6716

1.37

19.30

1.2

1.3

—

Appendectomy

1272

9237

1.32

19.28

1.3

—

Schizophrenia or delusion, excluding more controls

538

3501

1.53

19.20

1.3

—

Other necrotizing vasculopathies (FG)

144

638

2.33

19.19

1.5

1.3

—

Dislocation, sprain and strain of joints and ligaments at neck level

315

1827

1.76

19.12

1.3

—

Persons encountering health services for specific procedures, not carried out

187

919

2.08

19.05

1.3

—

Pleural effusion

317

1845

1.75

19.04

1.4

1.3

—

Excessive earwax

1268

8784

1.32

18.87

1.3

—

Other disorders of the musculoskeletal system and connective tissue

321

1881

1.74

18.86

1.3

—

Myelodysplastic syndrome

5.00

18.80

3.5

1.2

—

Open wound of lower leg

328

1934

1.73

18.79

1.4

1.3

—

Coxarthrosis, primary

1185

7448

1.33

18.73

1.3

—

Assault

262

1449

1.84

18.71

1.3

—

Polycystic kidney disease

286

3.07

18.71

1.6

1.3

—

Fall on same level involving ice and snow

1178

8940

1.33

18.68

1.3

—

Familial hypercholesterolemia

298

1715

1.77

18.63

1.4

1.3

—

Haemorrhage, not elsewhere classified

357

2.79

18.60

1.3

1.2

—

Atopic dermatitis, strict definition with reimbursement

582

3775

1.50

18.46

1.3

—

IgA nephropathy (IgA glomerulonephritis)

241

3.25

18.38

1.4

—

Spontaneous rupture of synovium and tendon

181

892

2.08

18.35

1.4

—

Neuralgia and neuritis, unspecified

121

507

2.46

18.31

1.3

—

Myocardial infarction, without ST-elevation

761

4881

1.42

18.20

1.3

—

COPD, hospital admission 2, with asthma infections

619

3645

1.48

18.15

1.4

1.3

—

Other inflammation of eyelid

310

1819

1.74

18.13

1.4

1.3

—

Diseases of tongue

142

640

2.28

18.12

1.5

1.3

—

Obsessive-compulsive disorder

146

665

2.25

18.09

1.4

1.2

—

Iridocyclitis

464

3014

1.56

17.92

1.4

1.3

—

Excessive vomiting in pregnancy

183

914

2.05

17.91

1.3

—

Early onset COPD

427

2724

1.59

17.87

1.3

—

Kela-code for severe mental illness

695

4895

1.44

17.80

1.3

—

Acute gastritis

155

729

2.18

17.79

1.3

—

Benign neoplasm: Rectum

381

2374

1.63

17.69

1.3

—

COPD related to multimorbidity

748

4498

1.42

17.66

1.4

1.3

—

Sequelae of cerebrovascular disease

706

4249

1.43

17.66

1.3

—

Other (seronegative) rheumatoid arthritis, wide

402

2538

1.61

17.65

1.3

—

Lateral epicondylitis

255

1425

1.82

17.64

1.2

1.4

—

Other disorders of eyelid

870

6005

1.38

17.63

1.3

—

Malignant neoplasm of skin, including Hilmo

968

4784

1.37

17.61

1.3

1.2

—

Childhood asthma (age<16), excluding more controls

216

881

1.94

17.58

1.3

1.2

—

Dental pulpitis, including avohilmo

1824

9367

1.25

17.56

1.3

—

Anti-inflammatory and antirheumatic products, non-steroids

491

1584

1.57

17.54

1.3

—

Tonsillectomy and adenotomy

1061

5532

1.34

17.53

1.3

—

Disturbance of activity and attention

267

1477

1.79

17.51

1.2

1.3

—

Benign neoplasm of other and ill-defined parts of digestive system

383

2397

1.63

17.47

1.3

—

Skin changes due to chronic exposure to nonionizing radiation

786

5126

1.40

17.47

1.3

—

Otitis externa, unspecified

243

1344

1.85

17.46

1.4

1.3

—

Other noninfective disorders of lymphatic vessels and lymph nodes

376

2.69

17.40

1.5

1.3

—

Other symptoms and signs involving the urinary system

214

1139

1.92

17.37

1.3

—

Adenomyosis (Endometriosis of uterus)

265

1503

1.79

17.35

1.3

—

Fracture of lower leg, including ankle

1074

7984

1.33

17.34

1.4

1.3

—

Pacemaker

697

4581

1.43

17.29

1.3

—

Pyogenic arthritis

138

628

2.25

17.21

1.5

1.4

—

Diabetic neuropathy

248

1382

1.83

17.18

1.5

1.3

—

Dermatitis due to substances taken internally

133

598

2.30

17.16

1.4

1.3

—

Elevated blood glucose level

182

922

2.02

17.14

1.3

—

Implicit parasitic Sepsis, including avohilmo

6.48

17.13

1.7

1.4

—

Other chronic obstructive pulmonary disease, including avohilmo

1027

6338

1.34

17.11

1.4

1.3

—

Emotional disorders starting during childhood or adolecense, excluding more controls

359

2.66

17.10

1.3

1.2

—

COPD-related respiratory insufficiency

238

1317

1.85

17.09

1.5

1.3

—

Childhood asthma (age<16)

216

890

1.92

17.08

1.3

1.2

—

Injury of muscle and tendon at shoulder and upper arm level

679

4802

1.43

17.05

1.3

—

Acne vulgaris

177

887

2.03

17.03

1.3

—

Olecranon bursitis

125

549

2.34

16.98

1.2

1.4

—

Other respiratory disorders and diseases

401

2552

1.60

16.97

1.5

1.3

—

Other diseases of the respiratory system

401

2552

1.60

16.97

1.5

1.3

—

Sacroiliitis, not elsewhere classified

109

451

2.49

16.97

1.6

1.3

—

Type 1 diabetes

464

3044

1.54

16.96

1.3

—

Respiratory insufficiency

149

701

2.16

16.90

1.4

1.2

—

Chondropathies

307

1832

1.71

16.89

1.4

1.3

—

Psychotic depression

126

557

2.32

16.84

1.3

—

Right hemicolectomy

137

629

2.25

16.83

1.5

1.3

—

Superficial injury of abdomen, lower back and pelvis

324

1962

1.68

16.83

1.4

1.3

—

Acne

222

1200

1.87

16.83

1.3

—

Flat foot [pes planus] (acquired)

203

1074

1.93

16.80

1.3

—

Acute and subacute iridocyclitis

384

2427

1.61

16.78

1.4

1.3

—

Shigellosis, including avohilmo

6.21

16.71

1.4

1.3

—

Corns and callosities

154

742

2.14

16.70

1.4

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

1136

8256

1.31

16.70

1.4

1.3

—

Abnormal involuntary movements

288

1697

1.73

16.65

1.3

—

Ankylosing spondylitis, ICD10

181

925

2.00

16.63

1.5

1.4

—

Osteonecrosis

149

711

2.16

16.61

1.4

1.3

—

Viral pneumonia (unknown virus, not influenza)

148

705

2.16

16.50

1.7

1.3

—

Acquired absence of limb

5.12

16.47

1.3

1.4

—

Dislocation, sprain and strain of joints and ligaments of knee

1179

8224

1.31

16.43

1.3

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1255

8894

1.29

16.43

1.4

1.3

—

Chronic tubulo-interstitial nephritis

375

2.63

16.42

1.7

1.2

—

Degeneration of macula and posterior pole

947

5456

1.35

16.42

1.3

—

Hyperkinetic disorders

275

1562

1.74

16.41

1.2

1.3

—

Vulvovaginal ulceration/inflammation in other diseases

155

753

2.11

16.41

1.5

1.3

—

Maltreatment syndromes

121

533

2.34

16.39

1.2

1.3

—

Gout due to impairment of renal function

4.59

16.38

1.8

1.3

—

Sequelae of injuries, of poisoning and of other consequences of external causes

461

3051

1.53

16.36

1.3

—

Amputation of foot

247

3.06

16.35

1.3

1.4

—

Other noninflammatory disorders of vagina

167

835

2.05

16.32

1.4

1.3

—

Adhesive capsulitis of shoulder

313

1894

1.68

16.30

1.4

1.3

—

Cerebral palsy and other paralytic syndromes

227

1257

1.84

16.27

1.4

1.3

—

Ulcerative colitis (strict) with PSC

5.33

16.09

1.4

1.3

—

Chronic hepatitis, not elsewhere classified

362

2.65

16.07

1.5

1.3

—

Uterine polyps

517

2018

1.51

16.02

1.3

—

Lactose intolerance, other/unspecified

266

2.94

16.00

1.4

1.2

—

Necrosis of pulp, including avohilmo

1126

8579

1.31

16.00

1.3

—

Ganglion

384

2453

1.59

15.97

1.3

—

Amputation of thigh

266

2.93

15.96

1.5

1.3

—

Mental and behavioural disorders due to sedatives or hypnotics

147

708

2.13

15.94

1.3

—

Statin medication

1245

5418

1.30

15.91

1.3

—

Open wound of ankle and foot

207

1123

1.88

15.86

1.4

1.3

—

Follow-up care involving plastic surgery

382

2.58

15.82

1.6

1.2

—

Allergic urticaria

180

936

1.97

15.76

1.5

1.3

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

677

4855

1.41

15.76

1.3

—

Alcohol abuse, main dg

296

1783

1.69

15.73

1.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

873

4361

1.36

15.66

1.3

1.2

—

Other obstetric conditions, not elsewhere classified

593

2588

1.46

15.65

1.3

—

Seronegative rheumatoid arthritis

235

1333

1.80

15.57

1.3

—

Disorders of muscles

200

1080

1.89

15.54

1.3

1.4

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

111

483

2.38

15.54

1.6

1.2

—

Other diseases of pancreas

177

920

1.97

15.54

1.4

1.3

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

580

2520

1.46

15.52

1.3

—

Assault by bodily force

164

830

2.02

15.51

1.2

1.3

—

Fracture of skull and facial bones

411

2685

1.55

15.51

1.4

1.3

—

Actinic keratosis

753

5003

1.38

15.47

1.3

—

Diabetic retinopathy, excluding more controls

527

1993

1.50

15.40

1.4

1.3

—

COPD, early/later onset

843

5252

1.36

15.40

1.4

1.3

—

Acute generalized exanthematous pustulosis

112

492

2.36

15.37

1.4

—

Ulcer of oesophagus

139

666

2.14

15.30

1.4

1.3

—

Lactose intolerance

307

2.74

15.24

1.4

1.2

—

Lesion of ulnar nerve

270

1602

1.71

15.22

1.2

1.3

—

ILD, hospital admissions

306

1877

1.66

15.22

1.4

1.3

—

Haemorrhage in early pregnancy

542

3651

1.46

15.18

1.2

1.3

—

Unspecified misadventure during surgical and medical care

136

650

2.16

15.15

1.3

—

Other interstitial pulmonary diseases

309

1904

1.65

15.09

1.4

1.3

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

561

3921

1.45

15.09

1.3

—

Sequelae of other external causes

132

624

2.18

15.09

1.5

1.3

—

Chronic nephritic syndrome

373

2.56

15.09

1.5

1.4

—

Pneumonitis due to solids and liquids

166

852

1.99

15.09

1.4

1.3

—

Other general symptoms and signs

107

459

2.37

15.03

1.3

1.2

—

Mature T/NK-cell lymphomas, hilmo

141

3.74

14.97

2.8

1.3

—

Other inflammatory liver diseases

143

699

2.10

14.96

1.5

1.3

—

Thyroiditis, ILD-related definition

229

1305

1.79

14.95

1.3

—

Seborrhoeic dermatitis

199

1088

1.87

14.93

1.4

1.3

—

Symptoms and signs involving speech and voice

663

4784

1.40

14.92

1.3

—

Hallux rigidus

259

1530

1.72

14.85

1.3

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

173

908

1.96

14.81

1.4

1.3

—

Malignant neoplasm of skin

906

4606

1.34

14.79

1.3

1.2

—

COPD, hospital admissions

831

5219

1.35

14.79

1.4

1.3

—

Urolithiasis

589

4171

1.43

14.76

1.3

—

Anterior Iridocyclitis

400

2629

1.54

14.76

1.4

1.3

—

Interstitial lung disease

309

1915

1.64

14.76

1.4

1.3

—

Interstitial lung disease endpoints

309

1915

1.64

14.76

1.4

1.3

—

Autoimmune hepatitis, wide definition

419

2.43

14.74

1.6

1.3

—

Arthropathy in Crohn disease

110

4.15

14.72

1.5

1.3

—

ILD, hospital admissions 1, main diag only

278

1684

1.68

14.57

1.4

1.3

—

Superficial injury of shoulder and upper arm

248

1457

1.73

14.55

1.4

1.3

—

Other hearing loss

536

3622

1.45

14.52

1.3

—

Systemic lupus erythematosus

405

2.47

14.52

1.4

1.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

139

680

2.09

14.48

1.4

1.3

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

227

1303

1.77

14.46

1.3

—

Other and unspecified visual disturbances

232

1342

1.77

14.45

1.4

1.3

—

Generalized skin eruption due to drugs and medicaments

424

2.42

14.44

1.4

1.3

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

569

4023

1.43

14.40

1.3

—

Injuries to the elbow and forearm

1425

9798

1.25

14.40

1.3

—

Other/unspecified synovitis and tenosynovitis

220

1253

1.79

14.39

1.4

1.3

—

Hypermobility syndrome

122

571

2.20

14.33

1.3

—

Radiculopathy

295

1819

1.65

14.33

1.3

—

Other contact dermatitis

167

876

1.95

14.28

1.4

1.3

—

Covid-19 suspected case

406

2695

1.53

14.27

1.4

1.3

—

Type 1 diabetes, wide definition, subgroup 1

378

2468

1.55

14.27

1.3

—

Inflammatory diseases of the central nervous system

172

912

1.93

14.25

1.3

—

Open wound of forearm

198

1097

1.84

14.25

1.4

1.3

—

Calculus of kidney and ureter

549

3866

1.44

14.24

1.3

—

Ischaemic Stroke, excluding all haemorrhages

1049

5963

1.30

14.24

1.4

1.3

—

Dependence on enabling machines and devices, not elsewhere classified

4.58

14.21

1.5

1.3

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS